All NIH Institutes and Centers report their actual obligations each fiscal year by budget mechanism. The tables below display NCI funding by mechanism and division. The number of awards, trainees, or employees for each mechanism, as well as the dollar amount and percent share of the total NCI budget for each funding mechanism is also included.
NCI Obligations by Mechanism
Other Research mechanisms includes the following grants: Career Programs (K Awards), Cancer Education, Clinical Cooperative Groups, Pre-Doc Post-Doc Transition Awards, Minority Biomedical Research Support, Research Pathway in Residency, Resource Grants, International Research Training grants, Cooperative Conference Agreements, and Conference grants.
All items in italics are non add entries.
*Includes FY 2018 Cures-Moonshot funding.
*Excludes FY 2017 Cures-Moonshot carryover obligations.
NCI Obligations by Mechanism, FY 2018
(Whole Dollars)
| Type of Mechanism |
Mechanism |
Number |
Amount |
% of Total Amount |
| Research Project Grants (RPGs) |
Non-Competing |
3,338
|
$1,699,682,348 |
28.7% |
| Administrative Supplements |
280 |
36,754,377 |
0.6% |
| Competing |
1,162 |
571,221,786 |
9.6% |
| Subtotal, without SBIR/STTR Grants |
4,500 |
$2,307,658,511 |
38.9% |
| SBIR/STTR Grants |
280 |
142,899,233 |
2.4% |
| Subtotal, RPGs |
4,780 |
$2,450,557,744 |
41.3% |
| Centers & SPOREs |
Cancer Centers Grants-P20/P30 |
91 |
331,429,940 |
5.6% |
| SPOREs-P50 |
55 |
115,829,834 |
2.0% |
| Other P50s/P20s |
0 |
0 |
0.0% |
| Other Specialized Centers |
92 |
178,315,713 |
3.0% |
| Subtotal, Centers |
238 |
$625,575,487 |
10.6% |
| Other Research |
Career Program |
|
|
0.0% |
| Post-Doc-Fellow Awards-K00 |
30 |
2,293,876 |
0.0% |
| Temin & Minority Mentored Awards-K01/K43 |
41 |
5,979,795 |
0.1% |
| Estab. Inv. Award-K-05 |
5 |
444,131 |
0.2% |
| Preventive Oncology-K07 |
73 |
11,271,537 |
0.4% |
| Clinical Investigator-K08 |
113 |
20,858,368 |
0.2% |
| Clinical Oncology-K12 |
21 |
14,228,491 |
0.2% |
| Transitional Career Development-K22 |
58 |
10,304,211 |
0.0% |
| Mentored Patient Oriented RCDA-K23 |
13 |
2,165,733 |
0.0% |
| Mid-Career Invest. & Patient Orient. Res-K24 |
13 |
2,379,742 |
0.0% |
| Mentored Quant. Res Career-K25 |
6 |
847,484 |
0.1% |
| Pathway to Independence Awards K99 |
59 |
7,564,148 |
1.3% |
| Subtotal, Career Program |
432 |
$78,337,516 |
1.3% |
| Cancer Education Program-R25(including BD2K) |
76 |
21,181,892 |
0.4% |
| Clinical Cooperative Groups-U10/UG1 |
101 |
255,340,505 |
4.3% |
| PreDoc PostDoc Transition Awards-F99 |
47 |
1,769,662 |
0.0% |
| Minority Biomedical Support-S06 |
0 |
97,802 |
0.0% |
| Research Pathway in Residency-R38 |
1 |
358,020 |
0.0% |
| Resource Grants-R24/U24 |
90 |
179,028,691 |
3.0% |
| Int'l Rsrch Training Grants Conference- D43/U2R |
|
943,987 |
0.0% |
| Cooperative Conference Agreements-U13 |
2 |
9,000 |
0.0% |
| Conference Grants-R13 |
46 |
798,659 |
0.0% |
| Subtotal, Career and Other Research Grants |
795 |
$537,865,734 |
9.1% |
| Subtotal, Research Grants |
|
5,813 |
$3,613,998,965 |
61.0% |
| National Research Service Award (NRSA) Fellowships |
Trainees |
1,532 |
82,413,198 |
1.4% |
| R&D Contracts |
R&D Contracts |
402 |
752,280,456 |
12.7% |
| SBIR Contracts |
45 |
24,363,729 |
0.4% |
| NIH Management Fund/SSF Assessment |
|
48,761,825 |
0.8% |
| Subtotal, Contracts |
402 |
$825,406,010 |
13.9% |
| Intramural Research |
Program |
|
739,537,951 |
12.5% |
| NIH Management Fund/SSF Assessment |
|
205,957,758 |
3.5% |
| Subtotal, Intramural Research (FTEs) |
1,709 |
$945,495,709 |
16.0% |
| Research Management & Support (RMS) |
Research Management and Support (RMS) |
|
340,686,109 |
5.7% |
| SBIR RMS |
|
0 |
0.0% |
| NIH Management Fund/SSF Assessment |
|
101,729,113 |
1.7% |
| Subtotal, RMS (FTEs) |
1,243 |
$442,415,222 |
7.5% |
| Buildings & Facilities |
|
|
18,000,000 |
0.3% |
| *Total NCI |
(FTEs) |
2,952 |
$5,927,729,104 |
100.0% |
Division Obligations by Mechanism
Division Obligations
Total Division Obligations, FY 2018
(Whole Dollars)
| Division |
Total |
| Center for Cancer Research (CCR) |
$448,457,653 |
| Division of Cancer Epidemiology and Genetics (DCEG) |
105,897,928 |
| Division of Cancer Treatment and Diagnosis (DCTD) |
529,420,747 |
| Division of Cancer Biology (DCB) |
108,920,638 |
| Division of Cancer Control and Population Sciences (DCCPS) |
125,506,592 |
| Division of Cancer Prevention (DCP) |
196,721,315 |
| Division of Extramural Activities (DEA) |
22,575,736 |
| Office of the Director (OD) |
1,485,904,925 |
| Total Division |
$3,023,405,534 |
Center for Cancer Research (CCR)
CCR Obligations
(Whole Dollars)
| Type of Mechanism |
Mechanism |
Amount |
| Intramural Research |
Program |
$448,457,653 |
| NIH Management Fund |
0 |
| Total CCR |
|
$448,457,653 |
Division of Cancer Epidemiology and Genetics (DCEG)
DCEG Obligations
(Whole Dollars)
| Type of Mechanism |
Mechanism |
Amount |
| R&D Contracts |
R&D Contracts |
$26,519,224 |
| SBIR Contracts |
0 |
| Intramural Research |
Program |
79,378,704 |
| NIH Management Fund |
0 |
| Total DCEG |
|
$105,897,928 |
Division of Cancer Treatment and Diagnosis (DCTD)
DCTD Obligations
(Whole Dollars)
| Type of Mechanism |
Mechanism |
Amount |
| Centers & SPOREs |
Cancer Centers Grants-P20/P30 |
$0 |
| SPOREs-P50 |
111,504,723 |
| Other P50s/P20s |
0 |
| U54s |
14,212,588 |
| Subtotal, Centers |
$125,717,311 |
| Other Research–Grants |
Cancer Education Program-R25 |
0 |
| Clinical Cooperative Groups-U10/UG1 |
136,773,118 |
| Minority Biomedical Support-S06 |
0 |
| Sci Eval-U09/T09 & Rsch Enhance-SC1 |
0 |
| Continuing Education |
0 |
| Resource Grants-R24/U24 |
0 |
| Explor Coop Agreement-U56 |
0 |
| Global Infect. Disease Rsrch Training Prog - D43 |
0 |
| Conference Grants-R13/U13 |
0 |
| Subtotal, Other Research-Grants |
$136,773,118 |
| Subtotal, Research Grants |
|
$262,490,429 |
| R&D Contracts |
R&D Contracts |
211,716,905 |
| SBIR Contracts |
0 |
| Subtotal, Contracts |
$211,716,905 |
| Research Management & Support (RMS) |
RMS |
55,213,413 |
| SBIR RMS |
0 |
| NIH Management Fund |
0 |
| Subtotal, RMS |
$55,213,413 |
| Total DCTD |
|
$529,420,747 |
Division of Cancer Biology (DCB)
DCB Obligations
(Whole Dollars)
| Type of Mechanism |
Mechanism |
Amount |
| Centers & SPOREs |
Cancer Centers Grants-P20/P30 |
$0 |
| SPOREs-P50 |
0 |
| Other P50s/P20s |
0 |
| U54s |
97,099,895 |
| Subtotal, Centers |
$97,099,895 |
| Other Research-Grants |
Subtotal, Other Research–Grants |
$97,099,895 |
| Research Management & Support (RMS) |
RMS |
11,820,743 |
| SBIR RMS |
0 |
| NIH Management Fund |
0 |
| Subtotal, RMS |
$11,820,743 |
| Total DCB |
|
$108,920,638 |
Division of Cancer Control and Population Sciences (DCCPS)
DCCPS Obligations
(Whole Dollars)
| Type of Mechanism |
Mechanism |
Amount |
| Centers & SPOREs |
Cancer Centers Grants-P20/P30 |
$0 |
| SPOREs-P50 |
0 |
| Other P50s/P20s |
0 |
| U54s |
475,000 |
| Subtotal, Centers |
$475,000 |
| Cancer Education Program-R25 |
|
| Clinical Cooperative Groups-U10/UG1 |
679,899 |
| PreDoc PostDoc Transition Awards-F99 |
|
| Minority Biomedical Support-S06 |
|
| Research Pathway in Residency-R38 |
|
| Resource Grants-R24/U24/U2C |
700,000 |
| Global Infect. Disease Rsrch Training Prog - D43/U2R |
|
| Cooperative Conference Agreements-U13 |
|
| Conference Grants-R13 |
74,250 |
| Subtotal, Other Research Grants |
$1,453,149 |
| Subtotal, Research Grants |
$1,928,149 |
| R&D Contracts |
R&D Contracts |
88,479,872 |
| SBIR Contracts |
0 |
| Subtotal, Contracts |
$88,479,872 |
| Research Management & Support (RMS) |
RMS |
35,098,571 |
| SBIR RMS |
0 |
| NIH Management Fund |
0 |
| Subtotal, RMS |
$35,098,571 |
| Total DCCPS |
|
$125,506,592 |
Division of Cancer Prevention (DCP)
DCP Obligations
(Whole Dollars)
| Type of Mechanism |
Mechanism |
Amount |
| Centers & SPOREs |
Cancer Centers Grants-P20/P30 |
$0 |
| SPOREs-P50 |
0 |
| Other P50s/P20s |
0 |
| U54s |
2,346,884 |
| Subtotal, Centers |
$2,346,884 |
| Other Research–Grants |
Cancer Education Program-R25 |
0 |
| Clinical Cooperative Groups-U10/UG1 |
112,164,519 |
| Minority Biomedical Support-S06 |
0 |
| Sci Eval-U09/T09 & Rsch Enhance-SC1 |
0 |
| Continuing Education |
0 |
| Resource Grants-R24/U24 |
0 |
| Explor Coop Agreement-U56 |
0 |
| Global Infect. Disease Rsrch Training Prog - D43 |
0 |
| Conference Grants-R13/U13 |
0 |
| Subtotal, Other Research Grants |
$112,164,519 |
| Subtotal, Research Grants |
|
$114,511,303 |
| R&D Contracts |
R&D Contracts |
56,472,670 |
| SBIR Contracts |
0 |
| Subtotal, Contracts |
$56,472,670 |
| Research Management & Support (RMS) |
RMS |
25,737,342 |
| SBIR RMS |
0 |
| NIH Management Fund |
0 |
| Subtotal, RMS |
$25,737,342 |
| Total DCP |
|
$196,721,315 |
Division of Extramural Activities (DEA)
DEA Obligations
(Whole Dollars)
| Type of Mechanism |
Mechanism |
Amount |
| Research Management & Support (RMS) |
RMS |
$22,575,736 |
| SBIR RMS |
0 |
| NIH Management Fund |
0 |
| Total DEA |
$22,575,736 |
Office of the Director (OD)
OD Obligations
(Whole Dollars)
| Type of Mechanism |
Mechanism |
Amount |
| Research Project Grants (RPGs) |
Non-Competing |
$0 |
| Administrative Supplements |
0 |
| Competing |
0 |
| Subtotal, without SBIR/STTR Grants |
$0 |
| SBIR/STTR Grants |
142,899,233 |
| Subtotal, RPGs |
$142,899,233 |
| Centers & SPOREs |
Cancer Centers Grants-P20/P30 |
331,429,940 |
| SPOREs-P50 |
4,325,111 |
| Other P50s/P20s |
0 |
| U54s |
64,181,446 |
| Subtotal, Centers |
$399,936,497 |
| Other Research–Career Program |
Career Program |
0 |
| Post-Doc-Fellow Awards-K00 |
2,293,876 |
| Temin & Minority Mentored Awards-K01 |
5,979,795 |
| Estab. Inv. Award-K05 |
444,131 |
| Preventive Oncology-K07 |
11,271,537 |
| Clinical Investigator-K08 |
20,858,368 |
| Clinical Oncology-K12 |
14,228,491 |
| Transitional Career Development-K22 |
10,304,211 |
| Mentored Patient Oriented RCDA-K23 |
2,165,733 |
| Mid-Career Invest. & Patient Orient. Res-K24 |
2,379,742 |
| Mentored Quant. Res Career-K25 |
847,484 |
| Pathway Award-K99 |
7,564,148 |
| Subtotal, Career Program |
$78,337,516 |
| Other Research–Grants |
Cancer Education Program-R25 |
21,181,892 |
| Clinical Cooperative Groups-U10/UG1 |
5,723,969 |
| Minority Biomedical Support-S06 |
1,769,662 |
| Sci Eval-U09/T09 & Rsch Enhance-SC1 |
0 |
| Continuing Education |
0 |
| Resource Grants-R24/U24 |
0 |
| Explor Coop Agreement-U56 |
0 |
| Global Infect. Disease Rsrch Training Prog - D43 |
0 |
| Conference Grants-R13/U13 |
0 |
| Subtotal, Other Research–Grants |
$28,675,523 |
| Subtotal, Research Grants |
|
$649,848,769 |
| NRSA Fellowships |
|
82,413,198 |
| R&D Contracts |
R&D Contracts |
314,126,912 |
| SBIR Contracts |
24,363,729 |
| NIH Management Fund/SSF Assessment/Program Evaluation |
0 |
| Subtotal, Contracts |
$338,490,641 |
| Intramural Research |
Program |
211,701,594 |
| NIH Management Fund/SSF Assessment/Program Evaluation |
0 |
| Subtotal, Intramural Research |
$211,701,594
|
| Research Management & Support (RMS) |
RMS |
190,240,303 |
| SBIR RMS |
0 |
| NIH Management Fund/SSF Assessment/Program Evaluation |
0 |
| Subtotal, RMS |
$190,240,303 |
| Buildings and Facilities |
|
18,000,000 |
| Total OD |
|
$1,485,904,925 |
